JNJ · News · 20260914N
340B Claims-Data Requirement
JOHNSON & JOHNSON · 2026-09-14 · Importance 37 · Surprise 42 · In source text
Johnson & Johnson now requires hospitals and clinics to submit claims data for each drug dispensed under the federal 340B program to receive applicable discounts. The policy became effective September 14, 2026, and is intended by J&J to prevent duplicative discounts and potential program abuse. Healthcare providers contend that the requirement could restrict access to discounts that help them afford high-priced prescription medicines, creating regulatory and reimbursement risk.
Key facts
- Johnson & Johnson is now requiring hospitals and clinics to submit claims data for each drug dispensed under the federal 340B program to receive discounts, with the policy effective Tuesday. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | unclear | committed | — | Johnson & Johnson is now requiring hospitals and clinics to submit claims data for each drug dispensed under the federal 340B program to… |